Structural Abnormalities in the Papillary and Peripapillary Areas and Corresponding Visual Field Defects in Eyes With Pathologic Myopia.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 04 2022
Historique:
entrez: 21 4 2022
pubmed: 22 4 2022
medline: 26 4 2022
Statut: ppublish

Résumé

To identify structural abnormalities in the papillary and peripapillary area in eyes with pathologic myopia (PM) and normal IOP and to determine their relationship to visual field (VF) defects. One hundred eight eyes of 70 patients with PM were retrospectively studied. The disc-centered swept source optical coherence tomographic images and the Goldmann VF recorded within 1 year of the optical coherence tomographic examination were analyzed. Four structural abnormalities were identified: lamina cribrosa (LC) defects, ridge protrusions, intrachoroidal cavitations (ICC), and prelaminar schisis. The correspondence of the VF defects with the structural abnormalities was assessed. The mean age, axial length, and optic disc area of the 108 eyes were 58.7 ± 10.0 years, 31.1 ± 2.4 mm, and 4.7 ± 2.2 mm2, respectively. Eighty-five of the 108 eyes (78.7%) had at least one abnormality and 49.4% (42/85) had two or more abnormalities. LC defects, ridge protrusions, ICC, and prelaminar schisis were detected in 47.2%, 33.3%, 21.3%, and 30.6% of the eyes, respectively. VF defects at the corresponding areas of these structural abnormalities were seen in 63% of the eyes with LC defects, 39% of the eyes with ridge protrusions, and 21% of the eyes with ICC. Four kinds of structural abnormalities with corresponding VF defects are commonly observed in the papillary and peripapillary region of eyes with PM. The presence of these abnormalities suggests a possibility of functional damage.

Identifiants

pubmed: 35446343
pii: 2778761
doi: 10.1167/iovs.63.4.13
pmc: PMC9034715
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13

Références

PLoS One. 2017 Aug 23;12(8):e0182816
pubmed: 28832670
Ophthalmology. 2014 Jan;121(1):110-118
pubmed: 24144452
PLoS One. 2015 Oct 01;10(10):e0138825
pubmed: 26425846
Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4075-83
pubmed: 20237247
JAMA Ophthalmol. 2013 Mar;131(3):314-20
pubmed: 23370812
Invest Ophthalmol Vis Sci. 1990 Mar 1;31(3):512-20
pubmed: 2318590
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3750-3758
pubmed: 28738419
J Biomed Opt. 2017 Dec;22(12):1-11
pubmed: 29247496
Prog Retin Eye Res. 2016 May;52:156-87
pubmed: 26769165
Am J Ophthalmol. 2011 Aug;152(2):256-265.e1
pubmed: 21664594
J Glaucoma. 2012 Jan;21(1):1-6
pubmed: 21173704
Transl Vis Sci Technol. 2017 Jul 18;6(4):9
pubmed: 28729947
Ophthalmology. 2011 Oct;118(10):1989-1994.e2
pubmed: 21684603
Invest Ophthalmol Vis Sci. 2019 Jan 2;60(1):26-35
pubmed: 30601928
Am J Ophthalmol. 2021 Mar;223:246-258
pubmed: 33166501
Retina. 2012 Jun;32(6):1037-44
pubmed: 22466483
Ophthalmology. 2010 Sep;117(9):1705-12
pubmed: 20591487
Invest Ophthalmol Vis Sci. 2013 Jul 18;54(7):4798-807
pubmed: 23778878
J Clin Med. 2021 Jun 25;10(13):
pubmed: 34202033
Ophthalmology. 2000 Oct;107(10):1809-15
pubmed: 11013178
Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30
pubmed: 30817826
Am J Ophthalmol. 2019 Jul;203:89-102
pubmed: 30825418
PLoS One. 2013 Oct 24;8(10):e78743
pubmed: 24302981
Trans Am Ophthalmol Soc. 1977;75:67-86
pubmed: 613534
Prog Retin Eye Res. 2019 May;70:99-109
pubmed: 30537538
Ophthalmology. 2017 Nov;124(11):1600-1611
pubmed: 28551164
Prog Retin Eye Res. 2005 Jan;24(1):39-73
pubmed: 15555526
Arch Ophthalmol. 2006 Jan;124(1):46-52
pubmed: 16401784
Ophthalmology. 2014 Sep;121(9):1798-809
pubmed: 24813630
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):5
pubmed: 33909033
Am J Ophthalmol. 2021 Dec;232:17-29
pubmed: 34153266
Am J Ophthalmol. 2015 May;159(5):877-83.e7
pubmed: 25634530
Ophthalmology. 2007 Nov;114(11):2070-6
pubmed: 17543388

Auteurs

Shiqi Xie (S)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Koju Kamoi (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Tae Igarashi-Yokoi (T)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Kengo Uramoto (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Hiroyuki Takahashi (H)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Noriko Nakao (N)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Kyoko Ohno-Matsui (K)

Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH